Gemstone BioTherapeutics
Baltimore, US · Founded 2013 · Maryland LLC
Biotech
Founders & leadership
GD
George DavisExecutive
SG
Sharon GerechtNamed on SEC filing
Board
DO
David OrosBoard director
XH
Xin HuangBoard director
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 2 rounds · 2015–2016
▶$700KraisedOct 2016 · 5 investors · BiotechnologyRule 506(b)
▶$700KraisedOct 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George DavisExecutive Officer, Director, Promoter
- David OrosDirector, Promoter
- GEOFF MACKAYDirector
- Xin HuangDirector
- Offering amount
- $3.5M
- Amount sold
- $700K
- Minimum investment
- $100K
- First sale
- Oct 2016
- Incorporated
- Limited Liability Company, Maryland, 2013
- Federal exemptions
- 06b
▶$1.6MraisedJun 2015 · 3 investors · BiotechnologyRule 506(b)
▶$1.6MraisedJun 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sharon GerechtDirector
- George DavisExecutive Officer, Director, Promoter
- Xin HuangDirector
- David OrosDirector, Promoter
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $100K
- First sale
- Jun 2015
- Incorporated
- Limited Liability Company, Maryland, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Gemstone BioTherapeutics raised?
- Gemstone BioTherapeutics has disclosed $2.3M raised across 2 rounds.
- Where is Gemstone BioTherapeutics headquartered?
- Gemstone BioTherapeutics is headquartered in Baltimore, US.